Position in PCVX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$14,270,915
+$725,474 QoQ
Shares Held
245,500
+5.3% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#69
of 329 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. PCVX ranks #25 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in PCVX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,270,915 | 245,500 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $13,545,441 | 233,100 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $10,630,656 | 230,400 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,108,102 | 225,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,194,463 | 221,300 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,205,248 | 217,300 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $17,927,340 | 219,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $20,637,162 | 180,600 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $13,689,963 | 181,300 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $12,159,180 | 178,000 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $9,288,120 | 147,900 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,876,410 | 154,500 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,441,060 | 149,000 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,471,364 | 119,300 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $6,027,315 | 125,700 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,992,000 | 83,000 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,732,096 | 79,600 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,207,500 | 50,000 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,091,961 | 45,900 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,139,113 | 44,900 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,010,699 | 44,900 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $681,375 | 34,500 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $916,665 | 34,500 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||